Clinical Trial

Conservative Treatment With Blood Flow Restriction in Patients With Total ACL Rupture. "Randomized Clinical Trial"

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomised clinical trial is to evaluate the effects of exercise with blood flow restriction (BFR) in patients with a complete anterior cruciate ligament (ACL) rupture. The main questions it aims to answer are: 1. Does blood flow restriction adds any additional benefits to conservative treatment of the ACL? 2. Does bracing promotes spontaneous healing to the ACL Researchers will compare bracing and BFR to bracing and sham BFR to see if the intervention provides any additional benefits to the conservative management of this injury. Participants will: 1. Use a knee brace for 6 weeks with adjustments according to protocol 2. Follow and identical exercise plan with either BFR (intervention group) or BFR sham (control group) 3. Follow a home based exercise program.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-06.
Trial Details
NCT Number NCT06727344
Lead Sponsor European University Cyprus
Conditions ACL, ACL - Anterior Cruciate Ligament Rupture
Enrollment 20 participants
Start Date 2025-02-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-03